About
SYNthesis BioVentures is a dedicated investment fund specializing in early-stage therapeutics, with a particular focus on small molecule therapeutics, biologics, and innovative cell and gene therapies that address significant unmet medical needs. By strategically investing in promising biotechnology ventures, SYNthesis BioVentures aims to bridge the funding gap within the Australian biotech ecosystem, fostering the development of groundbreaking solutions that can enhance patient outcomes. The firm is committed to supporting visionary entrepreneurs and pioneering research that has the potential to transform healthcare and improve lives. Through its comprehensive expertise and extensive network, SYNthesis BioVentures is poised to drive advancements in the biotech sector.